FLUOROTECHNICS BOARD

Richard Trevillion
Chairman and Managing Director

Appointed in December 2010
Member of Audit and Risk Committee and Member of Remuneration and Nomination Committee

Richard is the founder of Amity Partners and Adillion Pty Ltd, both principal financial investment and corporate consulting businesses. He previously served as Head of healthcare within the technology corporate finance group at Close Brothers Corporate Finance.

Damian Pethica
Executive Director

Appointed in December 2010
Member of Audit and Risk Committee and Member of Remuneration and Nomination Committee

Dr Pethica worked for Ciba-Geigy in Basel, Switzerland, as a group head in the Medical Department, Pharmaceutical Division, then as Medical Director in New Zealand. Following the merger of Ciba-Geigy and Sandoz he was Medical Director of Novartis New Zealand. He subsequently joined Flemings in London as a biotechnology equities research analyst. After the acquisition of Flemings he was Vice President, Biotechnology Equity Research for Europe for JPMorgan Chase. He was Chairman of BrainZ Instruments Ltd (ASX: BZI) in 2008-9 and negotiated the sale of its assets to Natus Medical (NASDAQ: BABY).

Dr. Pethica was educated at Oxford University (mathematics) and London University (medicine), and was in medical practice for over 7 years. He is a Fellow of the Faculty of Pharmaceutical Physicians, Royal College of Physicians, London and a current member of the Medicines Assessment Advisory Committee, New Zealand.

Rick Taylor
B.Econ., ACA, MAICD
Executive Director

Appointed in March 2002
Member of Audit and Risk Committee and Member of Remuneration and Nomination Committee

Rick is a founder and Chairman of Fluorotechnics Limited. He is a chartered accountant with 30 years experience and is a member of the Australian Institute of Company Directors.

He was formerly a tax partner for 20 years with Deloitte and its antecedent firms. In this role, he was a lead partner in structuring and advising on mergers and acquisitions, helping companies IPO and structuring funding arrangements across a broad range of industries.

He has strategy and management expertise gained from establishing and leading the Deloitte Australia Private Equity Team and from being a member of their National Tax Executive. For 4 consecutive years, Rick was voted one of Australia’s top ten and recommended tax advisors in surveys conducted by the International Tax Review journal.

Rick was a director of Hunter Hall International Limited until he resigned on 29 April 2010. Besides Fluorotechnics and Hunter Hall International, he has not been a director of any other Australian listed company in the last three years.

Interests in shares and options

• Ordinary shares 2,454,555
• Share options 180,000

Ian Gilmour
FCIS, CA, FAICD
Company Secretary

Appointed in October 2008
Fellow of the Institute of Chartered Secretaries and Administrators, Associate of the Institute of Chartered Accountants in Australia and Fellow of Australian Institute of Company Directors

Ian was the company secretary of Goodman Fielder Limited from 1979 to 2003, Biosignal Ltd from 2004 to 2006 and Medical Therapies Ltd from 2005 to 2007. Ian has also been a director and company secretary of Amazing Loans Ltd 2005 to 2007.

Currently, director and company secretary of AQRB Pty Limited (formerly Audit Quality Review Board Ltd) and Company Secretary of National E-Conveyancing Development Ltd, Benthic Geotech Pty Ltd, IEG Holdings Limited and a consultant to Complispace Pty Ltd. With Chartered Secretaries Australia, Ian is a member of the NSW Council and a number of committees.

Besides from being a director of Amazing Loans Ltd, Ian has not been a director of any other Australian listed company in the last three years.